Edwards Lifesciences receives FDA approval for tricuspid valve repair system

The US FDA granted approval to Edwards Lifesciences for its tricuspid valve repair system, expanding the company's treatment options for structural heart disease patients with tricuspid valve conditions.

Detected & updated continuously · Source: Nebula

Story subjects

Edwards Lifesciences CorpFood and Drug Administration

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula